C Ó'Fágáin, PM Cummins, BF O'Connor - … Chromatography: Methods and …, 2017 - Springer
Gel-filtration chromatography is a versatile method that permits the effective separation of biological molecules in high yield. This article describes the basis of the method, the …
Y Wu, J Simons, S Hooson, D Abraham… - … of Chromatography A, 2013 - Elsevier
The structural and protein adsorption characteristics of the perfusion chromatography matrix POROS® HS 50 are determined. Transmission electron microscopy shows a broad …
VBC Kumari, SM Patil, R Ramu, PS Shirahatti… - Analytical techniques in …, 2022 - Elsevier
Chromatography is regarded as one of the most significant bioanalytical techniques used in different branches of life sciences and chemistry. It allows the separation, identification, and …
Y Wu, D Abraham, G Carta - Journal of Chromatography A, 2016 - Elsevier
Structural and performance characteristics of perfusion chromatography media (POROS HS 20 and 50) and those of a polymethacrylate monolith (CIM SO3-1 tube monolith column) are …
M Castellanos, Z Cinza, Z Dorta, G Veliz… - The journal of gene …, 2010 - Wiley Online Library
Background In the present study, we evaluated the safety of CIGB‐230, a novel vaccine candidate based on the mixture of a plasmid for DNA immunization, expressing hepatitis C …
TSP Grandhi, A Mallik, KN Lin, B Miryala… - … applied materials & …, 2014 - ACS Publications
Plasmid DNA (pDNA) therapeutics are being investigated for gene therapy and DNA vaccines against diseases including cancer, cystic fibrosis and AIDS. In addition, several …
OR Hernández, ML Fernández, J Valdes… - 2011 - books.google.com
The use of gene therapy is a promising process for the prevention, treatment and cure of diseases such as cancer and acquired inmudeficiency syndrome (AIDS); increasing a …
M Limonta, NL Krajnc, U Vidic… - Biochemical engineering …, 2013 - Elsevier
The pIDKE2 plasmid is the main component of the CIGB's candidate vaccine against Hepatitis C virus (HVC), which is being used in HCV chronically-infected individuals during …
CIGB-230, a mixture of a DNA plasmid expressing hepatitis C virus (HCV) structural antigens and a HCV recombinant capsid protein, has demonstrated to elicit strong immune …